Radical radiotherapy for localized cutaneous angiosarcoma of the scalp

Katano,Atsuto; Yamashita,Hideomi; Nakagawa,Keiichi

doi:10.3892/mco.2021.2357

Radical radiotherapy for localized cutaneous angiosarcoma of the scalp

Authors:
- Atsuto Katano
- Hideomi Yamashita
- Keiichi Nakagawa
View Affiliations

Affiliations: Department of Radiology, The University of Tokyo Hospital, Bunkyo‑ku, Tokyo 113‑8655, Japan
Published online on: July 21, 2021 https://doi.org/10.3892/mco.2021.2357
Article Number: 195

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Angiosarcoma is a rare but highly aggressive sarcoma of mesenchymal origin with a high mortality rate. Due to its rarity, there are very limited reports on the clinical outcomes of angiosarcoma treated with radical radiotherapy. The aim of the present study was to evaluate the efficacy and feasibility of treating patients with radiotherapy for cutaneous angiosarcoma localized to the scalp at The University of Tokyo Hospital (Tokyo, Japan). The present study analyzed 15 consecutive patients treated for cutaneous angiosarcoma of the scalp with radiotherapy between June 2008 and January 2020. All patients were treated with 70 Gy of irradiation split into 35 fractions, focused on the lesion, including 9 patients who received total scalp radiotherapy. The median follow‑up period in all patients was 9.7 months. The median overall survival (OS) time was 20.7 months, and the 1‑, 2‑ and 5‑year OS rates were 56.2, 28.1 and 9.4%, respectively. At the time of analysis, 13 patients (86.7%) developed recurrence. Among these 13 patients, the first site of recurrence was the scalp as local recurrence in 7 patients (46.7%), parotid recurrence in 2 patients (13%) and distant metastasis in 4 patients (26.7%). No patient exhibited grade 3‑5 radiation‑induced late toxicity. Therefore, the present study revealed the clinical outcomes of radical radiotherapy for cutaneous angiosarcoma of the scalp.

View Figures

View References

1	Conic RRZ, Damiani G, Frigerio A, Tsai S, Bragazzi NL, Chu TW, Mesinkovska NA, Koyfman SA, Joshi NP, Budd GT, et al: Incidence and outcomes of cutaneous angiosarcoma: A SEER population-based study. J Am Acad Dermatol. 83:809–816. 2020.PubMed/NCBI View Article : Google Scholar
2	Young RJ, Brown NJ, Reed MW, Hughes D and Woll PJ: Angiosarcoma. Lancet Oncol. 11:983–991. 2010.PubMed/NCBI View Article : Google Scholar
3	Huang J and Mackillop WJ: Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer. 92:172–180. 2001.PubMed/NCBI View Article : Google Scholar
4	Meis-Kindblom JM and Kindblom LG: Angiosarcoma of soft tissue: A study of 80 cases. Am J Surg Pathol. 22:683–697. 1998.PubMed/NCBI View Article : Google Scholar
5	Painter CA, Jain E, Tomson BN, Dunphy M, Stoddard RE, Thomas BS, Damon AL, Shah S, Kim D, Gómez Tejeda Zañudo J, et al: The angiosarcoma project: Enabling genomic and clinical discoveries in a rare cancer through patient-partnered research. Nat Med. 26:181–187. 2020.PubMed/NCBI View Article : Google Scholar
6	Gaballah AH, Jensen CT, Palmquist S, Pickhardt PJ, Duran A, Broering G and Elsayes KM: Angiosarcoma: Clinical and imaging features from head to toe. Br J Radiol. 90(20170039)2017.PubMed/NCBI View Article : Google Scholar
7	Wang L, Lao IW, Yu L and Wang J: Clinicopathological features and prognostic factors in angiosarcoma: A retrospective analysis of 200 patients from a single Chinese medical institute. Oncol Lett. 14:5370–5378. 2017.PubMed/NCBI View Article : Google Scholar
8	Shon W and Billings SD: Cutaneous malignant vascular neoplasms. Clin Lab Med. 37:633–646. 2017.PubMed/NCBI View Article : Google Scholar
9	Ohsawa M, Naka N, Tomita Y, Kawamori D, Kanno H and Aozasa K: Use of immunohistochemical procedures in diagnosing angiosarcoma. Evaluation of 98 cases. Cancer. 75:2867–2874. 1995.PubMed/NCBI View Article : Google Scholar
10	Mankey CC, McHugh JB, Thomas DG and Lucas DR: Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas. Histopathology. 56:364–371. 2010.PubMed/NCBI View Article : Google Scholar
11	Morgan MB, Swann M, Somach S, Eng W and Smoller B: Cutaneous angiosarcoma: A case series with prognostic correlation. J Am Acad Dermatol. 50:867–874. 2004.PubMed/NCBI View Article : Google Scholar
12	Fury MG, Antonescu CR, Van Zee KJ, Brennan MF and Maki RG: A 14-year retrospective review of angiosarcoma: Clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J. 11:241–247. 2005.PubMed/NCBI View Article : Google Scholar
13	Pawlik TM, Paulino AF, McGinn CJ, Baker LH, Cohen DS, Morris JS, Rees R and Sondak VK: Cutaneous angiosarcoma of the scalp: A multidisciplinary approach. Cancer. 98:1716–1726. 2003.PubMed/NCBI View Article : Google Scholar
14	Karnofsky DA and Burchenal JH: Evaluation of chemotherapeutic agents. In: The Clinical Evaluation of Chemotherapeutic Agents in Cancer. MacLeod CM, editor. Columbia University Press, New York, pp191-205, 1949.
15	Takenaka R, Haga A, Nawa K, Hideomi Y and Nakagawa K: Improvement of the robustness to set up error by a virtual bolus in total scalp irradiation with Helical tomotherapy. Radiol Phys Technol. 12:433–437. 2019.PubMed/NCBI View Article : Google Scholar
16	Hata M, Wada H, Ogino I, Omura M, Koike I, Tayama Y, Odagiri K, Kasuya T and Inoue T: Radiation therapy for angiosarcoma of the scalp: Treatment outcomes of total scalp irradiation with X-rays and electrons. Strahlenther Onkol. 190:899–904. 2014.PubMed/NCBI View Article : Google Scholar
17	Ogawa K, Takahashi K, Asato Y, Yamamoto Y, Taira K, Matori S, Iraha S, Yagi N, Yogi A, Haranaga S, et al: Treatment and prognosis of angiosarcoma of the scalp and face: A retrospective analysis of 48 patients. Br J Radiol. 85:e1127–e1133. 2012.PubMed/NCBI View Article : Google Scholar
18	Guadagnolo BA, Zagars GK, Araujo D, Ravi V, Shellenberger TD and Sturgis EM: Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp. Head Neck. 33:661–667. 2011.PubMed/NCBI View Article : Google Scholar
19	Ihara H, Kaji T, Katsui K, Miyake T, Waki T, Katayama N, Matsuzaki H, Yamasaki O, Kuroda M, Morizane S and Kanazawa S: Single institutional experience of radiation therapy for angiosarcoma of the scalp without cervical lymph node metastases: Impact of concurrent chemoradiation with maintenance chemotherapy using taxanes on patient prognosis. Mol Clin Oncol. 11:498–504. 2019.PubMed/NCBI View Article : Google Scholar
20	Fujisawa Y, Yoshino K, Kadono T, Miyagawa T, Nakamura Y and Fujimoto M: Chemoradiotherapy with taxane is superior to conventional surgery and radiotherapy in the management of cutaneous angiosarcoma: A multicentre, retrospective study. Br J Dermatol. 171:1493–1500. 2014.PubMed/NCBI View Article : Google Scholar
21	Mark RJ, Poen JC, Tran LM, Fu YS and Juillard GF: Angiosarcoma. A report of 67 patients and a review of the literature. Cancer. 77:2400–2406. 1996.PubMed/NCBI View Article : Google Scholar
22	Florou V, Rosenberg AE, Wieder E, Komanduri KV, Kolonias D, Uduman M, Castle JC, Buell JS, Trent JC and Wilky BA: Angiosarcoma patients treated with immune checkpoint inhibitors: A case series of seven patients from a single institution. J Immunother Cancer. 7(213)2019.PubMed/NCBI View Article : Google Scholar